Datar Cancer Genetics Private Limited
IndiaFDA applicant, unverified FDA FEI 3024236768
- Devices
- 1
- Registrations
- FDA
- FDA recalls
- 0
At a glance
Market reach
- United States
- FDA FEI
What Datar Cancer Genetics Private Limited makes
Datar Cancer Genetics Private Limited manufactures CellDx-Tissue, a diagnostic device used for analyzing tissue samples to support cancer genetics testing and molecular profiling.
The company’s portfolio is regulated under Class II medical devices and includes submissions via the FDA’s 510(k) pathway. The company is based in India.
Catalogue
CellDx-Tissue Ref K260235
Regimes: 510(k) Registry: 510(k)
Company details
- FDA FEI number
- 3024236768
- Address
- F-8, D Road, Ambad, Nasik Maharashtra
Frequently asked questions
How many devices does Datar Cancer Genetics Private Limited have in the registry?
The registry currently lists 1 device for Datar Cancer Genetics Private Limited. Devices recorded under merged duplicate company entries are counted once.
Which registries list Datar Cancer Genetics Private Limited's devices?
Among its 1 most recently registered device, Datar Cancer Genetics Private Limited has devices listed in FDA 510(k) (1 device).
What risk classes do Datar Cancer Genetics Private Limited's devices fall under?
Among its 1 most recently registered device, the classes recorded for Datar Cancer Genetics Private Limited's devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Datar Cancer Genetics Private Limited in the registry?
The most recently registered devices listed for Datar Cancer Genetics Private Limited include CellDx-Tissue.